Cargando…

‘Hotspots’ of Antigen Presentation Revealed by Human Leukocyte Antigen Ligandomics for Neoantigen Prioritization

The remarkable clinical efficacy of the immune checkpoint blockade therapies has motivated researchers to discover immunogenic epitopes and exploit them for personalized vaccines. Human leukocyte antigen (HLA)-binding peptides derived from processing and presentation of mutated proteins are one of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller, Markus, Gfeller, David, Coukos, George, Bassani-Sternberg, Michal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654951/ https://www.ncbi.nlm.nih.gov/pubmed/29104575 http://dx.doi.org/10.3389/fimmu.2017.01367

Ejemplares similares

High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome
por: Chong, Chloe, et al.
Publicado: (2018)

Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome*
por: Mylonas, Roman, et al.
Publicado: (2018)

Predicting Antigen Presentation—What Could We Learn From a Million Peptides?
por: Gfeller, David, et al.
Publicado: (2018)

Analysis of Secondary Structure Biases in Naturally Presented HLA-I Ligands
por: Perez, Marta A. S., et al.
Publicado: (2019)

Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length Preference
por: Marino, Fabio, et al.
Publicado: (2020)

Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation
por: Bassani-Sternberg, Michal, et al.
Publicado: (2015)

Editorial: Immunopeptidomic Approaches for the Identification of Tumor (neo)Antigens
por: Lill, Jennie R., et al.
Publicado: (2022)

HLA ligandome tumor antigen discovery for personalized vaccine approach
por: Rammensee, Hans-Georg, et al.
Publicado: (2013)

Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity
por: Mommen, Geert P. M., et al.
Publicado: (2016)

The HLA Ligandome Comprises a Limited Repertoire of O-GlcNAcylated Antigens Preferentially Associated With HLA-B*07:02
por: Mukherjee, Soumya, et al.
Publicado: (2021)

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
por: Newey, Alice, et al.
Publicado: (2019)

Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity
por: Bassani-Sternberg, Michal, et al.
Publicado: (2017)

Antigen Presentation Profiling Reveals Recognition of Lymphoma Immunoglobulin Neoantigens
por: Khodadoust, M.S., et al.
Publicado: (2017)

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients
por: Bassani-Sternberg, Michal, et al.
Publicado: (2019)

The Connection Between Minor H Antigens and Neoantigens and the Missing Link in Their Prediction
por: Mutis, Tuna, et al.
Publicado: (2020)

Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal
por: Bianchi, Valentina, et al.
Publicado: (2020)

Development of antigen‐prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse
por: Charneau, Jimmy, et al.
Publicado: (2022)

Deciphering the landscape of phosphorylated HLA-II ligands
por: Solleder, Marthe, et al.
Publicado: (2022)

Tumour‐associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles
por: Kumar, Pankaj, et al.
Publicado: (2022)

Sensitive identification of neoantigens and cognate TCRs in human solid tumors
por: Arnaud, Marion, et al.
Publicado: (2021)

Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure
por: Vigano, Selena, et al.
Publicado: (2020)

Antigen-Presenting Cells and Antigen Presentation in Tertiary Lymphoid Organs
por: Hughes, Catherine E., et al.
Publicado: (2016)

The Role of FcRn in Antigen Presentation
por: Baker, Kristi, et al.
Publicado: (2014)

Cardiac Non-Human Leukocyte Antigen Identification: Techniques and Troubles
por: Gates, Katherine V., et al.
Publicado: (2017)

Spondyloarthritis and the Human Leukocyte Antigen (HLA)-B(*)27 Connection
por: Kavadichanda, Chengappa G., et al.
Publicado: (2021)

APRANK: Computational Prioritization of Antigenic Proteins and Peptides From Complete Pathogen Proteomes
por: Ricci, Alejandro D., et al.
Publicado: (2021)

Antigen Presentation in the Lung
por: Kawasaki, Takumi, et al.
Publicado: (2022)

Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery
por: Zhang, Bing, et al.
Publicado: (2023)

Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma
por: Mohsen, Mona O, et al.
Publicado: (2022)

Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
por: Irving, Melita, et al.
Publicado: (2017)

Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen
por: Hickey, Michelle J., et al.
Publicado: (2016)

Orf Virus-Based Vectors Preferentially Target Professional Antigen-Presenting Cells, Activate the STING Pathway and Induce Strong Antigen-Specific T Cell Responses
por: Müller, Melanie, et al.
Publicado: (2022)

The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors
por: Jasinski-Bergner, Simon, et al.
Publicado: (2022)

Sequence-Based Genotyping of Expressed Swine Leukocyte Antigen Class I Alleles by Next-Generation Sequencing Reveal Novel Swine Leukocyte Antigen Class I Haplotypes and Alleles in Belgian, Danish, and Kenyan Fattening Pigs and Göttingen Minipigs
por: Sørensen, Maria Rathmann, et al.
Publicado: (2017)

T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4
por: Coles, Charlotte H., et al.
Publicado: (2020)

POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction
por: Meng, Qingqing, et al.
Publicado: (2020)

Targeting the MHC Ligandome by Use of TCR-Like Antibodies
por: Høydahl, Lene Støkken, et al.
Publicado: (2019)

Antigen Presentation by Vascular Cells
por: Pober, Jordan S., et al.
Publicado: (2017)

Antigen Cross-Presentation by Macrophages
por: Muntjewerff, Elke M., et al.
Publicado: (2020)

Antigen Processing and Remodeling of the Endosomal Pathway: Requirements for Antigen Cross-Presentation
por: Compeer, Ewoud Bernardus, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_hj8hpogiakpsojk5hr4pe345lv